Venous and arterial thrombosis following extracorporeal photopheresis: A descriptive cohort study using a federated electronic health record network
Transfusion · 2026
DOI: 10.1111/trf.70300 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Transfusion, 2026. Verfasst von Caitlin Raymond. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Electronic Health Records, Photopheresis, Thrombosis, Venous Thrombosis. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In 2018, the FDA reported VTE events in patients undergoing ECP, but these reports lacked a population‐level denominator to contextualize the risk against the known baseline thrombotic burden of the underlying conditions. Study Design and Methods We conducted a descriptive retrospective cohort study using the TriNetX federated EHR network. Patients undergoing ECP with no thrombosis codes in the preceding 6 months or 1 year were identified. The primary outcome was new VTE within 5 and 30 days of the index procedure. Secondary analyses examined VTE subtypes and stratified risk by indication (GVHD vs. CTCL).
Results
Among 3006 patients (1‐year thrombosis exclusion), the 30‐day VTE risk was 6.0% (95% CI, 5.2%–6.9%) and the 5‐day risk was 1.4% (95% CI, 1.0%–1.8%); estimates were consistent across thrombosis exclusion periods. Kaplan–Meier analysis showed gradual event accumulation without periprocedural clustering. VTE risk at 30 days was markedly higher in GVHD patients (8.1%; 95% CI, 6.8%–9.5%) than CTCL patients (3.3%; 95% CI, 2.1%–5.0%). Among GVHD patients, upper extremity DVT, PE, and lower extremity DVT contributed approximately equally. Arterial thrombotic events were infrequent (1.5% at 30 days).
Conclusion
VTE following ECP occurs at a rate consistent with baseline thrombotic risk in the underlying populations and does not cluster periprocedurally, strongly suggesting that patient‐level factors rather than the procedure drive the observed risk. A small contributory procedural effect cannot be excluded without a controlled comparator study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
ORCID-Profile: Caitlin Raymond
Zitieren
APA
Raymond, C. (2026). Venous and arterial thrombosis following extracorporeal photopheresis: A descriptive cohort study using a federated electronic health record network. Transfusion. https://doi.org/10.1111/trf.70300
Vancouver
Raymond C. Venous and arterial thrombosis following extracorporeal photopheresis: A descriptive cohort study using a federated electronic health record network. Transfusion. 2026. doi:10.1111/trf.70300
BibTeX
@article{Raymond2026,
author = {Raymond, Caitlin},
title = {Venous and arterial thrombosis following extracorporeal photopheresis: A descriptive cohort study using a federated electronic health record network},
journal = {Transfusion},
year = {2026},
doi = {10.1111/trf.70300}
}
EUVIMED